LTR 125: Kevin Schawinski on Building Trustworthy AI and MedTech Readiness

Case Study: Comparing EU and FDA Cybersecurity Guidance for Medical Devices

LTR 124: Omar Al Kalaa on Wireless Coexistence and Risk in Connected Medical Devices

LTR 123: Richard Matt on Effective Risk Communication

Case Study: What AI/ML Device Recalls Reveal About Emerging Risks

LTR 122: Tibor Zechmeister on PSUR Best Practices

LTR 121: Michelle Lott on Risk, CAPA and FDA Inspections under QMSR

Case Study: Contrasting U.S. and EU Approaches to AI Regulation

LTR 120: Atty Chakraborty on India's Rising MedTech Sector

LTR 119: AI, Risk and Regulatory Strategy with Dr. Jay Vaishnav

Case Study: When Clues to a Future Recall Hide in Plain Sight

LTR 118: Off-Label Use with Kristen Petersen

LTR 117: Queenita Fernandes on Smart Use of AI for Clinical Evaluation

A Quick Primer on FDA's Final Guidance for Cybersecurity in Medical Devices

LTR 116: Priyanka Murawala on ISO 10993 Update, Biocompatibility, Learning from Recalls

LTR 115: Startup Lessons from EU MedTech Shark Tank

LTR 114: What QA/RA Professionals Need to Know About Rapidly Growing MedTech in India

Case Study: When Underestimating Risk Leads to a Warning Letter

LTR 113: Highlights from the International Medical Device Safety Risk Management Conference

LTR 112: Overcoming organizational barriers to risk management through collaboration